CEO
Dr. Nazari, PhD in AI and Nuclear Medicine, is CEO and Co-Founder of PharmAI. With over 8 years in the pharmaceutical industry, he leads the company’s mission to transform drug discovery through artificial intelligence.
President
Dr. Kluge is founder and director of ABX-CRO with over 20 years’ experience in nuclear medicine, molecular imaging, and radiopharmaceutical development. He advises PharmAI on clinical translation and strategy.
CTO
Dr. Leberecht is an experienced bioinformatician with a background in systems and structural biology. As CTO, he combines his scientific expertise with a passion for software architecture, ensuring PharmAI’s platforms are efficient, reliable, and scalable.
CFO
Andreas Fintelmann is a lawyer and seasoned executive with extensive experience in management, finance, and sales. As CFO, he brings strategic and financial leadership to PharmAI.
CSO
Michael Schröder, Ph.D., Prof., his work spans AI/ML, network biology, and computational drug repositioning; he advises PharmAI on algorithmic strategy and discovery.
CBO
Moritz Kallerhoff brings extensive business expertise, holding two MBAs and a strong background in strategy and partnerships. He is passionate about identifying new opportunities while fostering trustful, long-term collaborations.
Chief Strategy Officer (CSO)
Dr. Schubart, PhD in Genetics, brings over a decade of experience in translational research and clinical project leadership. At PharmAI, she drives strategic science and partnerships.
Advisor
Dr. Kramer is a medicinal chemist and physician with extensive experience in radiopharmaceuticals, molecular imaging, and theranostics. He advises PharmAI on translational strategies bridging chemistry and clinical application.
Bioinformatics Expert
Dr. Bittrich is a computational biologist with expertise in structural bioinformatics and molecular modeling. At PharmAI, he contributes to advancing structural prediction and analysis workflows.
Project Manager
Dr. Mohan holds a PhD in molecular imaging and oncology with broad expertise in theranostics and tumor microenvironment research. At PharmAI, he leads the design and execution of preclinical studies.
Senior Scientist
Background in molecular biology with a keen interest in computer science and passion in computational biology. Dr. Kasier holds a Ph.D. in computer science and has many years of research experience in structural bioinformatics.
Solution Expert
Dr. Haupt holds a Ph.D. in computer science with a strong background in structural bioinformatics and computational biology. With a decade of business experience and a long scientific track record, he combines entrepreneurship with science as the inventor of PharmAI’s DiscoveryEngine.
Artificial Intelligence Engineer
Rama holds an M.Sc. in Artificial Intelligence from Germany and brings many years of industrial experience. She contributes to the development of PharmAI’s DiscoveryEngine, advancing its AI capabilities.
Bioinformatics Engineer
Shanya is passionate about software development and AI - with a strong focus on smart and efficient solutions that make a real impact.